New Making AI Real Webinar Series
Home / Intelligence / Webinars / Unlock the Potential of Generative AI in Life Sciences Insights and Operations
Available On Demand
Generative AI (GenAI) has created an opportunity to re-think and significantly improve how we work. Although far from replacing humans, GenAI has the potential to make pharma professionals far more effective and valuable to their organizations.
Join us for “Making AI Real,” a webinar series from Trinity Life Sciences dedicated to exploring how to leverage generative AI across different areas within pharmaceutical commercial operations and medical affairs.
Our first webinar in this series will be on AI for Insights: discover how generative AI can transform the way your company interacts with and leverages its proprietary customer and market research. We will explore what “good” looks like now and where this technology is going in the future to enable Insights professionals to be more effective and valuable to their organizations.
In Case You Missed It
Watch the other webinars in our “Making AI Real” webinar series:
Featuring
Steven Laux
Vice President, Analytics &
Head of Generative AI
Patrick Waring
Director,
New Products & Strategy
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Analyst Reports
Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences
Everest Group report: AI-deas to Action: Operationalizing Generative AI in Life Sciences This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included. The report highlights several of Trinity’s key strengths, including: Life Sciences Industry Expertise Trinity […]
Read More
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now
Webinars
The Future of Patient Finding
Available On Demand
Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at […]
Watch Now